{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:54:14Z","timestamp":1789682054012,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejps.2024.106837","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T16:28:17Z","timestamp":1719851297000},"page":"106837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8614-0942","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengcai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejps.2024.106837_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520947627","article-title":"Initial dose recommendation for sirolimus in paediatric kaposiform haemangioendothelioma patients based on population pharmacokinetics and pharmacogenomics","volume":"48","author":"Chen","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejps.2024.106837_bib0018","article-title":"Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106837_bib0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/cpt.659","article-title":"Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future","volume":"101","author":"Darwich","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.ejps.2024.106837_bib0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200645110-00007","article-title":"Sirolimus population pharmacokinetic\/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients","volume":"45","author":"Djebli","year":"2006","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.ejps.2024.106837_bib0019","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/psp4.12096","article-title":"Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants","volume":"5","author":"Emoto","year":"2016","journal-title":"CPT. Pharmacometrics. Syst. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2024.106837_bib0002","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/dermatopathology8030039","article-title":"Diagnostic Approach to Congenital Cystic Masses of the Neck from a Clinical and Pathological Perspective","volume":"8","author":"Fanous","year":"2021","journal-title":"Dermatopathology. (Basel)"},{"issue":"3","key":"10.1016\/j.ejps.2024.106837_bib0001","first-page":"147","article-title":"Hemangiomas, cystic hygromas, and teratomas of the head and neck","volume":"3","author":"Filston","year":"1994","journal-title":"Semin. Pediatr. Surg."},{"issue":"12","key":"10.1016\/j.ejps.2024.106837_bib0013","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ejps.2024.106837_bib0014","first-page":"74","article-title":"Sirolimus-induced adverse reactions in children: a literature analysis","volume":"19","author":"Li","year":"2021","journal-title":"Clin. Med. J."},{"issue":"9","key":"10.1016\/j.ejps.2024.106837_bib0017","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1212\/WNL.0000000000201604","article-title":"Handling Delayed or Missed Dose of Antiseizure Medications: a Model-Informed Individual Remedial Dosing","volume":"100","author":"Li","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2024.106837_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2288-10-7","article-title":"Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study","volume":"10","author":"Marshall","year":"2010","journal-title":"BMC. Med. Res. Methodol."},{"key":"10.1016\/j.ejps.2024.106837_bib0011","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.ejps.2017.05.037","article-title":"Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies","volume":"109S","author":"Mizuno","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2024.106837_bib0023","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1038\/psp.2012.4","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT. Pharmacometrics. Syst. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106837_bib0025","first-page":"4","article-title":"National survey results of students' physical health in 2014","volume":"36","year":"2015","journal-title":"Chin. J. School Health"},{"issue":"4","key":"10.1016\/j.ejps.2024.106837_bib0005","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddu505","article-title":"Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations","volume":"24","author":"Osborn","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.ejps.2024.106837_bib0024","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/pharmaceutics13040470","article-title":"Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology","volume":"13","author":"Sabo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejps.2024.106837_bib0006","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1007\/s00405-023-07991-1","article-title":"Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review","volume":"280","author":"Saibene","year":"2023","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106837_bib0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/TP.0b013e3182384ae2","article-title":"Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients","volume":"92","author":"Sam","year":"2011","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ejps.2024.106837_bib0003","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/SCS.0b013e31825e3aac","article-title":"Lymphatic malformations in children and adolescents","volume":"23","author":"Schoinohoriti","year":"2012","journal-title":"J. Craniofac. Surg."},{"issue":"12","key":"10.1016\/j.ejps.2024.106837_bib0004","first-page":"1520","article-title":"Research progress on sirolimus in the treatment of lymphatic malformations","volume":"57","author":"Wang","year":"2022","journal-title":"Chin. J Otorhinolaryngol. Head Neck Surgery"},{"issue":"8","key":"10.1016\/j.ejps.2024.106837_bib0022","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s00405-022-07378-8","article-title":"Efficacy of sirolimus in children with lymphatic malformations of the head and neck","volume":"279","author":"Wiegand","year":"2022","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106837_bib0008","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1373\/clinchem.2013.204990","article-title":"Effect of CYP3A4\u00d722, POR*28, and PPARA rs4253728 on sirolimus in vitro metabolism and trough concentrations in kidney transplant recipients","volume":"59","author":"Woillard","year":"2013","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2024.106837_bib0021","first-page":"818","article-title":"Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipids","volume":"28","author":"Zahir","year":"2006","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.ejps.2024.106837_bib0016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/FTD.0b013e31825c6067","article-title":"Population pharmacokinetic model for adherence evaluation using lamivudine concentration monitoring","volume":"34","author":"Zhang","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.ejps.2024.106837_bib0007","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0091270007312902","article-title":"Pharmacokinetics of sirolimus (rapamycin) in subjects with severe hepatic impairment","volume":"48","author":"Zimmerman","year":"2008","journal-title":"J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T06:45:50Z","timestamp":1721976350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"alternative-id":["S0928098724001490"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106837","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106837"}}